{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T03:46:14Z","timestamp":1771472774744,"version":"3.50.1"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"University of Florida Jacksonville College of Medicine"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.ejphar.2018.01.035","type":"journal-article","created":{"date-parts":[[2018,2,4]],"date-time":"2018-02-04T07:42:43Z","timestamp":1517730163000},"page":"49-57","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Inhibition of hepatic apolipoprotein A-I gene expression by histamine"],"prefix":"10.1016","volume":"823","author":[{"given":"Michael J.","family":"Haas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica","family":"Plazarte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayham","family":"Chamseddin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luisa","family":"Onstead-Haas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norman C.W.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriela","family":"Plazarte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arshag D.","family":"Mooradian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2018.01.035_bib1","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1056\/NEJMoa1107579","article-title":"Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy","volume":"365","author":"AIM-HIGH Investigators","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2018.01.035_bib2","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/0046-8177(94)90271-2","article-title":"The association of mast cells and atherosclerosis: a morphologic study of early atherosclerotic lesions in young people","volume":"25","author":"Atkinson","year":"1994","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.ejphar.2018.01.035_bib3","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1124\/mol.60.5.1133","article-title":"Histamine H1-receptor activation of NF-\u03baB: roles for G\u03b2\u03b3 and G\u03b1q\/11-subunits in constitutive and agonist-mediated signaling","volume":"60","author":"Bakker","year":"2001","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejphar.2018.01.035_bib4","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1056\/NEJMoa0706628","article-title":"Effects of torcetrapib in patients at high risk for coronary events","volume":"357","author":"Barter","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2018.01.035_bib5","first-page":"6","article-title":"Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction","volume":"132","author":"Chomczynski","year":"1987","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ejphar.2018.01.035_bib6","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.5114\/aoms.2016.62906","article-title":"Inducing apolipoprotein A-I synthesis to reduce cardiovascular risk: from ASSERT to SUSTAIN and beyond","volume":"12","author":"Di Bartolo","year":"2016","journal-title":"Arch. Med. Sci."},{"key":"10.1016\/j.ejphar.2018.01.035_bib7","first-page":"2499","article-title":"Lipid-related markers and cardiovascular disease prediction","volume":"307","author":"Emerging Risk Factors Collaboration","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.ejphar.2018.01.035_bib8","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1365-3083.1989.tb01207.x","article-title":"Stimulation of histamine receptors of human monocytoid and hepatoma-derived cell lines and mouse hepatocytes modulates the production of the complement components C3, C4, factor B and C2","volume":"30","author":"Falus","year":"1989","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.ejphar.2018.01.035_bib9","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1161\/CIRCRESAHA.114.300760","article-title":"High-density lipoprotein and atherosclerosis regression: evidence from preclinical and clinical studies","volume":"114","author":"Feig","year":"2014","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2018.01.035_bib10","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/1755-5922.12265","article-title":"RVX-208: a novel BET protein inhibitor, role as an inducer of apo A-I.HDL and beyond","volume":"35","author":"Ghosh","year":"2017","journal-title":"Cardiovasc. Ther."},{"key":"10.1016\/j.ejphar.2018.01.035_bib11","first-page":"e6","article-title":"Heart disease and stroke Statistics-2013 Update: a report from the American Heart Association","volume":"127","author":"Go","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2018.01.035_bib12","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1128\/MCB.2.9.1044","article-title":"Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells","volume":"2","author":"Gorman","year":"1982","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.ejphar.2018.01.035_bib13","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.bbagen.2003.08.004","article-title":"Suppression of apolipoprotein AI gene expression in HepG2 cells by TNF \u03b1 and IL-1\u03b2","volume":"1623","author":"Haas","year":"2003","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejphar.2018.01.035_bib14","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1016\/j.metabol.2011.05.005","article-title":"Nicotinic acid induces apolipoprotein A-I gene expression in HepG2 and Caco-2 cell lines","volume":"60","author":"Haas","year":"2011","journal-title":"Metabolism"},{"key":"10.1016\/j.ejphar.2018.01.035_bib15","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/0092-8674(84)90472-0","article-title":"Two distinct enhancers with different cell specificities coexist in the regulatory region of polyoma","volume":"39","author":"Herbomel","year":"1984","journal-title":"Cell"},{"key":"10.1016\/j.ejphar.2018.01.035_bib16","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0031-6997(24)01328-0","article-title":"International Union of pharmacology. XIII. Classification of histamine receptors","volume":"49","author":"Hill","year":"1997","journal-title":"Pharm. Rev."},{"key":"10.1016\/j.ejphar.2018.01.035_bib17","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1056\/NEJMoa1300955","article-title":"Effects of extended-release niacin with laropiprant in high-risk patients","volume":"371","author":"HPS2-THRIVE Collaborative Group","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2018.01.035_bib18","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1161\/01.CIR.92.5.1084","article-title":"Infiltration of activated mast cells at the site of coronary atheromatous erosion or rupture in myocardial infarction","volume":"95","author":"Kovanen","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2018.01.035_bib19","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1475-2840-6-15","article-title":"Gene transfer of wild-type apoA-I and apoA-I Milano reduce atherosclerosis to a similar extent","volume":"6","author":"Lebherz","year":"2007","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.ejphar.2018.01.035_bib20","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1210\/endo.138.5.5115","article-title":"Novel effects of histamine on lipoprotein metabolism: suppression of hepatic low-density lipoprotein receptor expression and reduction of plasma high density lipoprotein cholesterol in the rat","volume":"138","author":"Liao","year":"1997","journal-title":"Endocrinol"},{"key":"10.1016\/j.ejphar.2018.01.035_bib21","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1172\/JCI10852","article-title":"Statin-induced inhibition of the Rho-signaling pathway activates PPARalpha and induces HDL apoA-I","volume":"107","author":"Martin","year":"2001","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ejphar.2018.01.035_bib22","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/BF01993163","article-title":"Histamine influences the expression of the interleukin-6 receptor on human lymphoid, monocytoid, and hepatoma cell lines","volume":"33","author":"Meretey","year":"1991","journal-title":"Agents Actions"},{"key":"10.1016\/j.ejphar.2018.01.035_bib23","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ejphar.2013.06.027","article-title":"Antihistaminergics and inverse agonism: potential therapeutic applications","volume":"715","author":"Monczor","year":"2013","journal-title":"Eur. J. Pharm."},{"key":"10.1016\/j.ejphar.2018.01.035_bib24","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/s40265-015-0390-1","article-title":"Targeting high-density lipoproteins: increasing de novo production versus decreasing clearance","volume":"75","author":"Mooradian","year":"2015","journal-title":"Drugs"},{"key":"10.1016\/j.ejphar.2018.01.035_bib25","doi-asserted-by":"crossref","first-page":"38188","DOI":"10.1074\/jbc.M306336200","article-title":"NFkappaB regulates plasma apolipoprotein A-I and high density lipoprotein cholesterol through inhibition of peroxisome proliferator-activated receptor alpha","volume":"278","author":"Morishima","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2018.01.035_bib26","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1161\/ATVBAHA.109.187518","article-title":"Structure and function of HDL mimetics","volume":"30","author":"Navab","year":"2010","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ejphar.2018.01.035_bib27","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1001\/jama.290.17.2292","article-title":"Effect of recombinant apo A-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial","volume":"290","author":"Nissen","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.ejphar.2018.01.035_bib28","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1089\/adt.2017.782","article-title":"High-throughput analysis to identify drugs that alter apolipoprotein A-I production","volume":"15","author":"Plazarte","year":"2017","journal-title":"Assay. Drug Dev. Technol."},{"key":"10.1016\/j.ejphar.2018.01.035_bib29","doi-asserted-by":"crossref","first-page":"G219","DOI":"10.1152\/ajpgi.00027.2014","article-title":"H1-antihistamines exacerbate high-fat diet-induced hepatic steatosis in wild-type but not in apolipoprotein E knockout mice","volume":"307","author":"Raveendran","year":"2014","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.ejphar.2018.01.035_bib30","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1006\/bbrc.2000.3868","article-title":"Activation of human peroxisome proliferator-activated receptor (PPAR) subtypes by pioglitazone","volume":"278","author":"Sakamoto","year":"2000","journal-title":"Biochem. Biophys. Res. Comm."},{"key":"10.1016\/j.ejphar.2018.01.035_bib31","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1056\/NEJMoa1206797","article-title":"Effects of dalcetrapib in patients with a recent acute coronary syndrome","volume":"367","author":"Schwartz","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2018.01.035_bib32","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1161\/CIRCRESAHA.108.182063","article-title":"Infusion of reconstituted high-density lipoprotein leads to acute changes in human atherosclerotic plaque","volume":"103","author":"Shaw","year":"2008","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2018.01.035_bib33","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.metabol.2016.03.002","article-title":"Effects of the BET-inhibito, RVX-208 on the HDL lipidome and glucose metabolism in individuals with pre-diabetes: a randomized controlled trial","volume":"65","author":"Siebel","year":"2016","journal-title":"Metabolism"},{"key":"10.1016\/j.ejphar.2018.01.035_bib34","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1001\/jama.298.7.786","article-title":"High-density lipoprotein as a therapeutic target: a systematic review","volume":"98","author":"Singh","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.ejphar.2018.01.035_bib35","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1021\/pr900057t","article-title":"Cell characterization by proteome profiling applied to primary hepatocytes and hepatocyte cell lines Hep-G2 and Hep-3B","volume":"9","author":"Slany","year":"2010","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.ejphar.2018.01.035_bib36","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/0003-2697(85)90442-7","article-title":"Measurement of protein using bicinchoninic acid","volume":"150","author":"Smith","year":"1985","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ejphar.2018.01.035_bib37","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/0022-1759(94)90034-5","article-title":"A tetrazolium-based colorimetric MTT assay to quantitate human monocyte mediated cytotoxicity against leukemic cells from cell lines and patients with acute myeloid leukemia","volume":"174","author":"van de Loosdrecht","year":"1994","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.ejphar.2018.01.035_bib38","doi-asserted-by":"crossref","first-page":"31012","DOI":"10.1016\/S0021-9258(18)47383-8","article-title":"Negative regulation of the human apolipoprotein A-I promoter by fibrates can be attenuated by the interaction of the peroxisome proliferator-activated receptor with its response element","volume":"269","author":"Vu-Dac","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2018.01.035_bib39","doi-asserted-by":"crossref","first-page":"25713","DOI":"10.1074\/jbc.273.40.25713","article-title":"The nuclear receptors peroxisome proliferator-activated receptor \u03b1 and Rev-erb\u03b1 mediate the species-specific regulation of apolipoprotein A-I expression by fibrates","volume":"273","author":"Vu-Dac","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2018.01.035_bib40","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s12265-017-9755-z","article-title":"Downregulation of the complement cascade in vitro, in mice and in patients with cardiovascular disease by the BET protein inhibitor apabetalone (RVX-208)","volume":"10","author":"Wasiak","year":"2017","journal-title":"J. Cardiovasc. Transl. Res."},{"key":"10.1016\/j.ejphar.2018.01.035_bib41","doi-asserted-by":"crossref","DOI":"10.1111\/pin.12246","article-title":"Novel function of histamine signaling in hyperlipidemia-induced atherosclerosis: histamine H1 receptors protect and H2 receptors accelerate atherosclerosis","author":"Yamada","year":"2015","journal-title":"Pathol. Int."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001429991830044X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001429991830044X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T14:42:28Z","timestamp":1751294548000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001429991830044X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":41,"alternative-id":["S001429991830044X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2018.01.035","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of hepatic apolipoprotein A-I gene expression by histamine","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2018.01.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2018 Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}